Abstract
Different types of infections in a community depend on the defense mechanism of the patient and surroundings of the patient. Early intervention can prevent hospital admission of the patient. Though the response to the treatment needs overall physiological condition of the patient. Healthcare-associated infections are common cause of increased cost of total care of patient in a hospital, morbidity, and mortality. Rapid identification of the source of infection and involvement in the body are helpful for better outcome. The infection may be viral, bacterial, parasitic, and fungal. The infection may be primary or secondary or others. Managing infection in a patient and response to the treatment are multifactorial like treating infection in an immune-compromised patient is a big challenge. The challenge also is more to the physician during treating a geriatric patient. Collection of history from the patient/relatives of patient is an initial tool for probable diagnosis. The methodical approaches of investigation, proper interpretation of the result, early initiation of treatment, and response to the treatment are essential for patient’s final outcome. The final outcome is also warranted by appropriate microbial and other supportive care of the hospital. Complexity of the situation needs close liaison between microbiologist, pathologist, infectious disease consultant, hematologist with quality of laboratory, and promptness of interrelationship within the hospital unit. While treating a subject, sometimes protective isolation for neutropenic and immune-compromised patients and source isolation of colonized and infected patients are essential. A new onset of fever in a patient admitted to hospital should be investigated, treated, and attended very sincerely. The reason could be manifold much as non-infectious causes, immunological cause, mild infection, or initial presence of severe infection. With increasing incidence of geriatric patient population, comorbidity, prolonged ICU stay, invasive therapies, use of broad-spectrum antibiotics, in-dwelling catheters, there is a rising incidence of fungal infection also. Candidemia, the common invasive fungal infection, is the fourth most common cause of bloodstream infection. Here, the sepsis markers like CRP have immense role since presentation of the patient to the healthcare facility till the outcome of the patient according to rising or decreasing CRP concentration of the patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- ABG:
-
Arterial blood gas
- ALL:
-
Acute lymphoblastic leukemia
- APACHE:
-
Acute physiology and chronic health evaluation
- APPs:
-
Acute phase proteins
- APTT:
-
Activated partial thromboplastin time
- BNP:
-
Natriuretic peptide
- CBG:
-
Capillary blood glucose
- cfDNA:
-
Cell-free DNA
- CRP:
-
C-reactive protein
- CRP/ALB:
-
C-reactive protein/albumin
- CSF:
-
Cerebrospinal fluid
- CT:
-
Computed tomography
- CVP:
-
Central venous pressure
- DAMPs:
-
Danger-associated molecule patterns
- DP:
-
Death probability
- ESR:
-
Erythrocyte sedimentation rate
- FIO2 :
-
Fraction of inspired oxygen
- GAS:
-
Group A streptococcus
- GBD:
-
Global Burden of Diseases, Injuries, and Risk Factors Study
- HCT:
-
Hematocrit
- hs-CRP:
-
High-sensitivity CRP
- ICU:
-
Intensive care unit
- IFN-γ:
-
Interferon gamma
- iGAS:
-
invasive GAS
- IL-1:
-
Interleukin 1
- IL10:
-
Interleukin 10
- IL-1β:
-
Interleukin 1 beta
- IL-6:
-
Interleukin 6
- LBP:
-
Lipopolysaccharide-binding protein
- LDLR:
-
Low-density lipoprotein receptor
- lncRNA:
-
Long noncoding RNAs
- LOS:
-
Length of stay
- LPS:
-
Lipopolysaccharides
- MALAT1:
-
Metastasis-associated lung adenocarcinoma transcript 1
- MDSCs:
-
Myeloid-derived suppressor cells
- MPO:
-
Myeloperoxidase
- NE:
-
Neutrophil elastase
- NET:
-
Neutrophil extracellular traps
- NEU count:
-
Neutrophil count
- NHIRD:
-
National Health Insurance Research Database
- NTproBNP:
-
N-terminal pro b-type natriuretic peptide
- PAI-1:
-
Plasminogen activator inhibitor-1
- PCO2 :
-
Partial pressure of carbon dioxide
- PCR:
-
Polymerase chain reaction
- PCSK9:
-
Proprotein convertase subtilisin/kexin type 9
- PCT:
-
Procalcitonin
- PIRO:
-
Predisposition, infection, response, organ dysfunction
- PLA2-II:
-
Group II phospholipase A2
- PO2 :
-
Partial pressure of oxygen
- POD:
-
Postoperative period
- PTT:
-
Partial thromboplastin time
- qSOFA:
-
quick SOFA
- RNS:
-
Reactive nitrogen species
- ROS:
-
Reactive oxygen species
- SAA:
-
Serum amyloid A protein
- SAPS 3:
-
Simplified Acute Physiology Score
- SCCM-ACCP:
-
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
- SIRS:
-
Systemic inflammatory response syndrome
- SOFA:
-
Sequential Organ Failure Assessment
- sRAGE:
-
Soluble form of the receptor for advanced glycation end products
- sTREM-1:
-
Soluble triggering receptor expressed on myeloid cells-1
- suPAR:
-
Soluble urokinase plasminogen activator receptor
- TNF-α:
-
Tumor necrosis factor-α
- WBC:
-
White blood cell
- WHO:
-
World Health Organization
References
Abdollahi A, Shoar S, Nayyeri F, Shariat M (2012) Diagnostic value of simultaneous measurement of procalcitonin, Interleukin-6 and hs-CRP in prediction of early-onset neonatal sepsis. Mediterr J Hematol Infect Dis 4(1):e2012028. https://doi.org/10.4084/MJHID.2012.028
American College of Chest Physicians/Society of Critical Care Medicine consensus conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20(6):864–874
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310. https://doi.org/10.1097/00003246-200107000-00002
Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515–518. https://doi.org/10.1016/0140-6736(93)90277-N
Basile-Filho A, Lago AF, Menegueti MG, Nicolini EA, Rodrigues LAB, Nunes RS, Auxiliadora-Martins M, Ferez MA (2019) The use of APACHE II, SOFA, SAPS 3, C-reactive protein/albumin ratio, and lactate to predict mortality of surgical critically ill patients: a retrospective cohort study. Medicine (Baltimore) 98(26):e16204. https://doi.org/10.1097/MD.0000000000016204
Bates DW, Sands K, Miller E, Lanken PN, Hibberd PL, Graman PS, Schwartz JS, Kahn K, Snydman DR, Parsonnet J, Moore R, Black E, Johnson BL, Jha A, Platt R (1997) Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis 176(6):1538–1551. https://doi.org/10.1086/514153
Becker KL, Snider R, Nylen ES (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 36:941–952
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709. https://doi.org/10.1056/NEJM200103083441001
Bloos F (2015) Clinical diagnosis of sepsis and the combined use of biomarkers and culture- and non-culture-based assays. Methods Mol Biol 1237:247–260. https://doi.org/10.1007/978-1-4939-1776-1_19
Bloos F, Reinhart K (2014 Jan 1) Rapid diagnosis of sepsis. Virulence 5(1):154–160
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644–1655
Bopp C, Hofer S, Weitz J, Bierhaus A, Nawroth PP, Martin E et al (2008) sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 147:79–83. https://doi.org/10.1016/j.jss.2007.07.014
Botero JSH, PĂ©rez MCF (2012) The history of sepsis from ancient Egypt to the XIX century. Intechopen
Bouza C, LĂ³pez-Cuadrado T, Saz-Parkinson Z, Amate-Blanco JM (2014) Epidemiology and recent trends of severe sepsis in Spain: a nationwide population-based analysis (2006–2011). BMC Infect Dis 14:3863. https://doi.org/10.1186/s12879-014-0717-7
Canabal JM, Kramer DJ (2008) Management of sepsis in patients with liver failure. Curr Opin Crit Care 14(2):189–197
Casserly B, Phillips GS, Schorr C, Dellinger RP, Townsend SR, Osborn TM et al (2015) Lactate measurements in sepsis induced tissue hypoperfusion. Crit Care Med 43:567–573
Chawla R, Todi S (2012) ICU protocols, a stepwise approach. Springer
Churpek MM, Zadravecz FJ, Winslow C, Howell MD, Edelson DP (2015) Incidence and prognostic value of the systemic inflammatory response syndrome and organ dysfunctions in ward patients. Am J Respir Crit Care Med 192(8):958–964. https://doi.org/10.1164/rccm.201502-0275OC
Chen YJ, Chen FL, Chen JH, Wu MM, Chen YL, Chien DS, Ko Y (2019) Epidemiology of sepsis in Taiwan. Medicine (Baltimore) 98(20):e15725. https://doi.org/10.1097/MD.0000000000015725
Cheng N, He R, Tian J, Ye PP, Ye RD (2008) Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 181:22–26
Crouser E, Exline M, Knoell D, Wewers MD (2008) Sepsis: links between pathogen sensing and organ damage. Curr Pharm Des 14(19):1840–1852
Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM, O’Malley KA, Wynn JL, Antonenko S, Al-Quran SZ, Swan R, Chung CS, Atkinson MA, Ramphal R, Gabrilovich DI, Reeves WH, Ayala A, Phillips J, Laface D, Heyworth PG, Clare-Salzler M, Moldawer LL (2007) MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 204(6):1463–1474
Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut J-F, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent J-L (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Intensive Care Med 34:783–785. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969965/. https://dx.doi.org/10.1007%2Fs00134-008-1040-9\tpmc_ext10.1007/s00134-008-1040-9
Deng M, Scott MJ, Loughran P, Gibson G, Sodhi C, Watkins S, Hackam D, Billiar TR (2013) Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis. J Immunol 190(10):5152–5160
Dhainaut JF, Marin N, Mignon A, Vinsonneau C (2001) Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 29(7 Suppl):S42–S47
Dombrovskiy VY, Martin AA, Sunderram J et al (2007) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35:1244–1250
Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, Pérez XL, Sirvent JM (2009) Edusepsis study group effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 180:861–866. https://doi.org/10.1164/rccm.200812-1912OC
Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff EA, Schein RM, Benjamin E, The Soluble TNF Receptor Sepsis Study Group (1996) Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N Engl J Med 334:1697–1702. https://doi.org/10.1056/NEJM199606273342603
Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, Angus DC, Reinhart K, International Forum of Acute Care Trialists (2016) Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 193(3):259–272. https://doi.org/10.1164/rccm.201504-0781OC
Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N (2018) The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med 6(3):223–230
Foreman MG, Mannino DM, Moss M (2003) Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 124:1016–1020. https://doi.org/10.1378/chest.124.3.1016
Fourrier F (2012) Severe sepsis, coagulation, and fibrinolysis. Crit Care Med 40:2704–2708
Freeman BD, Natanson C (2000) Anti-inflammatory therapies in sepsis and septic shock. Expert Opin Investig Drugs 9:1651–1663
Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454. https://doi.org/10.1056/NEJM199902113400607
Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162–174. https://doi.org/10.1038/nri2506
Gaieski DF, Edwards JM, Kallan MJ, Carr BG (2013) Benchmarking the incidence and mortality of severe sepsis in the United States*. Crit Care Med 41(5):1167–1174
Garcia-Alvarez M, Marik P, Bellomo R (2014) Sepsis-associated hyperlactatemia. Crit Care 18:503
Geng F, Liu W, Yu L (2019) Potential role of circulating long noncoding RNA MALAT1 in predicting disease risk, severity, and patients' survival in sepsis. J Clin Lab Anal 33(8):e22968. https://doi.org/10.1002/jcla.22968
Gonnert FA, Kunisch E, Gajda M, Lambeck S, Weber M, Claus RA et al (2012) Hepatic fibrosis in a long-term murine model of Sepsis. Shock 37(4):399–407
Gradel KO, Thomsen RW, Lundbye-Christensen S, Nielsen H, Schønheyder HC (2011) Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: a population-based cohort study. Clin Microbiol Infect 17(4):627–632. https://doi.org/10.1111/j.1469-0691.2010.03284.x
Gul F, Arslantaş MK, Cinel İ, Kumar A (2017) Changing definitions of Sepsis. Turk J Anaesthesiol Reanim 45:129–138
GĂ¼l F, ArslantaÅŸ MK, Cinel Ä°, Kumar A (2017) Changing definitions of sepsis. Turk J Anaesthesiol Reanim 45(3):129–138. https://doi.org/10.5152/TJAR.2017.93753
Gyawali B, Ramakrishna K, Dhamoon AS (2019) Sepsis: the evolution in definition, pathophysiology, and management. SAGE Open Med 7:2050312119835043. https://doi.org/10.1177/2050312119835043. eCollection 2019
Henriksen DP, Laursen CB, Jensen TG, Hallas J, Pedersen C, Lassen AT (2015) Incidence rate of community-cquired sepsis among hospitalized acute medical patients-a population-based survey. Crit Care Med 43(1):13–21. https://doi.org/10.1097/CCM.0000000000000611
Henriquez-Camacho C, Losa J (2014) Biomarkers for sepsis. Biomed Res Int 2014:547818. https://doi.org/10.1155/2014/547818
Hofer N, Zacharias E, M¨uller W, Resch B (2012) An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 102(1):25–36
Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150. https://doi.org/10.1056/NEJMra021333
Hotchkiss RS, Nicholson DW (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 6(11):813–822
Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13(3):260–268
Huerta LE, Rice TW (2019) Pathologic difference between Sepsis and bloodstream infections. J Appl Lab Med 3(4):654–663. https://doi.org/10.1373/jalm.2018.026245
Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM (2012) Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc 60(6):1070–1077
James JH, Luchette FA, McCarter FD, Fischer JE (1999) Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 354:505–508
Janković B, Pasić S, Marković M, Veljković D, Milicić M (2001) (C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis). Srp Arh Celok Lek 129(Suppl 1):17–22
Jarrar DWP, Chaudry IH (2001) Hepatocellular dysfunction–basic considerations. In: Holzheimer RGMJ (ed) Surgical treatment: evidence-based and problem-oriented. Zuckschwerdt, Munich
Jaye DL, Waites KB (1997) Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 16(8):735–747
Jincharadze N, Abelashvili D, McHedlishvili M, Kacharava M (2006) Diagnostic value of C-reactive protein test at early-onset sepsis in preterm infants. Georgian Med News 130:87–91
de Jong HK, van der Poll T, Wiersinga WJ (2010) The systemic pro-inflammatory response in sepsis. J Innate Immun 2:422–430. https://doi.org/10.1159/000316286
Kalil AC, Gilbert DN, Winslow DL, Masur H, Klompas M (2018) Infectious Diseases Society of America (IDSA) position statement: why IDSA did not endorse the surviving sepsis campaign guidelines. Clin Infect Dis 66:1631–1635
Kaukonen K, Bailey M, Suzuki S et al (2014) Mortality related to severe sepsis and septic shock among critically Ill patients in Australia and New Zealand, 2000–2012. JAMA 311(13):308–1316. https://doi.org/10.1001/jama.2014.2637
Kaukonen K-M, Bailey M, Pilcher D, Cooper DJ, Bellomo R (2015) Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 372(17):1629–1638. https://doi.org/10.1056/NEJMoa1415236. Epub 2015 Mar 17
Kanashvili B, Saganelidze K, Ratiani L (2018) The role of procalcitonin and blood lactic acid values in prognosis of sepsis and septic shock in polytrauma patients. Georgian Med News 279:102–107
Kepa L, Oczko-Grzesik B (2001) Usefulness of plasma C-reactive protein (CRP) estimation in patients with bacterial sepsis. Przegl Epidemiol 55(Suppl 3):63–67
Keshet R, Boursi B, Maoz R, Shnell M, Guzner-Gur H (2009) Diagnostic and prognostic significance of serum C-reactive protein levels in patients admitted to the department of medicine. Am J Med Sci 337(4):248–255. https://doi.org/10.1097/MAJ.0b013e31818af6de
Koo DJ, Chaudry IH, Wang P (1999) Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. J Surg Res 83(2):151–157
Koozi H, Lengquist M, Frigyesi A (2020) C-reactive protein as a prognostic factor in intensive care admissions for sepsis: a Swedish multicenter study. J Crit Care 56:73–79. https://doi.org/10.1016/j.jcrc.2019.12.009
Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Köhler G (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339–342. https://doi.org/10.1038/368339a0
Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG (2007) Incidence and prognosis of early hepatic dysfunction in critically ill patients--a prospective multicenter study. Crit Care Med 35(4):1099–1104
Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK (2012) Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 40(3):754–761. https://doi.org/10.1097/CCM.0b013e318232db65
Landry A, Docherty P, Ouellette S, Cartier LJ (2017) Causes and outcomes of markedly elevated C-reactive protein levels. Can Fam Physician 63:e316–e323
Lausević Z, Vuković G, Stojimirović B, Trbojević-Stanković J, Resanović V, Lausevic M (2010) Kinetics of C-reactive protein, interleukin-6 and -10, and phospholipase A2-II in severely traumatized septic patients. Vojnosanit Pregl 67(11):893–897
Lee SH, Hsu TC, Lee MG, Chao CC, Lee WC, Lai CC, Lee CC, National Taiwan University Health Economics and Outcome Research Group (2018) Nationwide trend of sepsis: a comparison among octogenarians, elderly, and young adults. Crit Care Med 46(6):926–934. https://doi.org/10.1097/CCM.0000000000003085
Lelubre C, Anselin S, Boudjeltia KZ, Biston P, Piagnerelli M (2013) Interpretation of C-Reactive protein concentrations in critically ill patients. Biomed Res Int 2013:124021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826426/. https://dx.doi.org/10.1155%2F2013%2F124021\tpmc_ext10.1155/2013/124021
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) SCCM/ESICM/ACCP/ATS/SIS 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256. https://doi.org/10.1097/01.CCM.0000050454.01978.3B
Li H, Shan-Shan Z, Jian-Qiang K, Ling Y, Fang L (2020) Predictive value of C-reactive protein and NT-pro-BNP levels in sepsis patients older than 75 years: a prospective, observational study. Aging Clin Exp Res 32(3):389–397. https://doi.org/10.1007/s40520-019-0124400
Liu GB, Cui XQ, Wang ZB, Wen L, Duan HL (2018) Detection of serum procalcitonin and hypersensitive C-reactive protein in patients with pneumonia and sepsis. J Biol Regul Homeost Agents 32(5):1165–1169
Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C, Vincent JL (2003) C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 123:2043–2049. https://doi.org/10.1378/chest.123.6.2043
Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A (2008) Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol 46(1):79–86
MacArthur RD, Miller M, Albertson T, Panacek E, Johnson D, Teoh L, Barchuk W (2004) Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis 38:284–288. https://doi.org/10.1086/379825
Marshall JC (2004) Sepsis: current status, future prospects. Curr Opin Crit Care 10(4):250–264
Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546–1554. https://doi.org/10.1056/NEJMoa022139
Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449:819–826. https://doi.org/10.1038/nature06246
Meehan M, Murchan S, Gavin PJ, Drew RJ, Cunney R (2018) Epidemiology of an upsurge of invasive group A streptococcal infections in Ireland, 2012-2015. J Infect 77(3):183–190. https://doi.org/10.1016/j.jinf.2018.05.010
Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24:680–684
Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K (1998) Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 24:185–188
Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA (2008 Apr 15) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111(8):4233–4244. https://doi.org/10.1182/blood-2007-07-099226
Owen J, Punt J, Stranford S (2013) Kuby immunology, 7th edn. W. H. Freeman, New York
Parrish WR, Gallowitsch-Puerta M, Czura CJ, Tracey KJ (2008) Experimental therapeutic strategies for severe sepsis: mediators and mechanisms. Ann N Y Acad Sci 1144:210–236. https://doi.org/10.1196/annals.1418.011
Pavcnik-Arnol M, Hojker S, Derganc M (2004) Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med 30(7):1454–1460
Peltola H, Jaakkola M (1988) Serious bacterial infections. C-reactive protein as a serial index of severity. Clin Pediatr (Phila) 27(11):532–537
Peltola H, Saarinen UM, Siimes MA (1983) C-reactive protein in rapid diagnosis and follow-up of bacterial septicemia in children with leukemia. Pediatr Infect Dis 2(5):370–373
Peters van Ton AM, Kox M, Abdo WF, Pickkers P (2018) Precision Immunotherapy for Sepsis. Immunol 9:1926. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133985/Front. https://dx.doi.org/10.3389%2Ffimmu.2018.01926\tpmc_ext10.3389/fimmu.2018.01926
Pierrakos C, Vincent JL (2010) Sepsis biomarkers: a review. Crit Care 14(1):R15. https://doi.org/10.1186/cc8872
Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E (1993) Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103:565–575
PĂ³voa P (2002) C-reactive protein: a valuable marker of sepsis. Intensive Care Med 28:235–243
PĂ³voa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H (2006) Early identification of intensive care unit-acquired infections with daily monitoring of C reactive. protein: a prospective observational study. Crit Care 10:R63
Protzer U, Maini MK, Knolle PA (2012) Living in the liver: hepatic infections. Nat Rev Immunol 12(3):201–213
Rannikko J, Jacome Sanz D, Ortutay Z, Seiskari T, Aittoniemi J, Huttunen R, Syrjänen J, Pesu M (2019) Reduced plasma PCSK9 response in patients with bacteraemia is associated with mortality. J Intern Med 286(5):553–561. https://doi.org/10.1111/joim.12946
Ravishankaran P, Shah AM, Bhat R (2011) Correlation of interleukin-6, serum lactate, and C-reactive protein to inflammation, complication, and outcome during the surgical course of patients with acute abdomen. J Interf Cytokine Res 31(9):685–690. https://doi.org/10.1089/jir.2011.0021
Recknagel P, Gonnert FA, Westermann M, Lambeck S, Lupp A, Rudiger A et al (2012) Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med 9(11):e1001338
Reinhart K, Bauer M, Riedemann NC, Hartog CS (2012) New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 25(4):609–634. https://doi.org/10.1128/CMR.00016-12
Reny J-L, Vuagnat A, Ract C, Benoit M-O, Safar M, Fagon J-Y (2002) Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 30:529–535
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486–552. https://doi.org/10.1097/CCM.0000000000002255
Riedemann NC, Guo RF, Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9:517–524. https://doi.org/10.1038/nm0503-517
Rintala EM, Aittoniemi J, Laine S, Nevalainen TJ, Nikoskelainen J (2001) Early identification of bacteremia by biochemical markers of systemic inflammation. Scand J Clin Lab Invest 61(7):523–530
Ritchie DG, Fuller GM (1983) Hepatocyte-stimulating factor: a monocyte-derived acute-phase regulatory protein. Ann N Y Acad Sci 408:490–502. https://doi.org/10.1111/j.1749-6632.1983.tb23268.x
Rittirsch D, Flierl MA, Ward PA (2008) Harmful molecular mechanisms in sepsis. Nat Rev Immunol 8:776–787. https://doi.org/10.1038/nri2402
Roger PM, Hung S, de Salvador F, Allieri-Rosenthal A, Farhad R, Pulcini C, Cua E (2009) Usefulness of C-reactive protein in the therapeutic follow-up of infected patients. Med Mal Infect 39(5):319–324. https://doi.org/10.1016/j.medmal.2009.03.001
Rohde JM, Odden AJ, Bonham C, Kuhn L, Malani PN, Chen LM, Flanders SA, Iwashyna TJ (2013) The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit. J Hosp Med 8:243–247. https://doi.org/10.1002/jhm.2012
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M (2020) Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study. Lancet 395(10219):200–211. https://doi.org/10.1016/S0140-6736(19)32989-7
Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, MĂ¼ller M, Blander JM, Tacke F, Trautwein C (2010) Hepatic acute phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 207(7):1453–1464
Santonocito C, De Loecker I, Donadello K, Moussa MD, Markowicz S, Gullo A, Vincent JL (2014) C-reactive protein kinetics after major surgery. Anesth Analg 119(3):624–629. https://doi.org/10.1213/ANE.0000000000000263
Say L, Chou D, Gemmill A, Tunçalp Ă–, Moller AB, Daniels J, GĂ¼lmezoglu AM, Temmerman M, Alkema L (2014) Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2(6):e323–e333. https://doi.org/10.1016/S2214-109X(14)70227-X
Schmit X, Vincent JL (2008) The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 36:213–219
Schottmueller H (1914) Wesen und Behandlung der sepsis. Inn Med 31:257–280
Schulte W, Bernhagen J, Bucala R (2013) Cytokines in sepsis: potent immunoregulators and potential therapeutic targets—an updated view. Mediat Inflamm 2013:1–16
Shah C, Hari-Dass R, Raynes JG (2006) Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood. 108:1751–1757. https://doi.org/10.1182/blood-2005-11-011932
Shiferaw B, Bekele E, Kumar K, Boutin A, Frieri M (2016) The role of procalcitonin as a biomarker in sepsis. J Infect Dis Epidemiol 2(1):006
Shimetani N, Shimetani K, Mori M (2001) Levels of three inflammation markers, C-reactive protein, serum amyloid a protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis. Scand J Clin Lab Invest 61(7):567–574
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8):801–810. https://doi.org/10.1001/jama.2016.0287
Stiel CU, Ebenebe CU, Trochimiuk M, Pagarols Raluy L, Vincent D, Singer D, Reinshagen K, Boettcher M (2020) Markers of NETosis do not predict neonatal early onset sepsis: a pilot study. Front Pediatr 7:555. https://doi.org/10.3389/fped.2019.00555. eCollection 2019
Sun R, Sun X, Yang H, Liu Q (2016) Retrospective analysis of serum C-reactive protein/albumin ratio for the prognosis of the adult patients with sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 28(5):413–417
Vincent J-L, Abraham E (2006) The last 100 years of sepsis. Am J Respir Crit Care Med 173:256–263
Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707–710
Wacker C, Prkno A, Brunkhorst FM, Schlattmann P (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 13:426–435. https://doi.org/10.1016/S1473-3099(12)70323-7
Weiss SJ, Guerrero A, Root-Bowman C, Ernst A, Krumperman K, Femling J, Froman P (2019) Sepsis alerts in EMS and the results of pre-hospital ETCO2. Am J Emerg Med 37(8):1505–1509. https://doi.org/10.1016/j.ajem.2018.11.009
World Health Organization (2011) WHO Report on the burden of endemic health care-associated infection worldwide. 2017-11-21 15:11:22
Wu Y, Wang F, Fan X, Bao R, Bo L, Li J, Deng X (2012) Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis. Crit Care 16(6):R229. https://doi.org/10.1186/cc11884
Yan J, Li S, Li S (2014) The role of the liver in sepsis. Int Rev Immunol 33(6):498–510
Yuan W, Zhang W, Yang X, Zhou L, Hanghua Z, Xu K (2018) Clinical significance and prognosis of serum tenascin-C in patients with sepsis. BMC Anesthesiol 18(1):170. https://doi.org/10.1186/s12871-018-0634-1
Zouki C, Beauchamp M, Baron C, Filep JG (1997) Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. J Clin Invest 100:522–529. https://doi.org/10.1172/JCI119561
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Habib, S.H., Ansar, W. (2020). Role of C-Reactive Protein (CRP) in Sepsis: Severity and Outcome. In: Ansar, W., Ghosh, S. (eds) Clinical Significance of C-reactive Protein. Springer, Singapore. https://doi.org/10.1007/978-981-15-6787-2_9
Download citation
DOI: https://doi.org/10.1007/978-981-15-6787-2_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-6786-5
Online ISBN: 978-981-15-6787-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)